Artiva Biotherapeutics, Inc. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Artiva Biotherapeutics, Inc. stock issued during period, value, stock options exercised for the quarter ending 2026-06-30 was $67.00K.
- Artiva Biotherapeutics, Inc. stock issued during period, value, stock options exercised for the quarter ending 2025-03-31 was $138.00K.
- Artiva Biotherapeutics, Inc. stock issued during period, value, stock options exercised for the quarter ending 2024-09-30 was $6.00K.
- Artiva Biotherapeutics, Inc. stock issued during period, value, stock options exercised for the quarter ending 2024-06-30 was $22.00K, a 120.00% increase year-over-year.
- Artiva Biotherapeutics, Inc. stock issued during period, value, stock options exercised for fiscal 2025 was $138.00K, a 170.59% increase from fiscal 2024.
- Artiva Biotherapeutics, Inc. stock issued during period, value, stock options exercised for fiscal 2024 was $51.00K, a 410.00% increase from fiscal 2023.
- Artiva Biotherapeutics, Inc. stock issued during period, value, stock options exercised for fiscal 2023 was $10.00K.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2026-06-30 | $67.00K 10-Q · filed 2026-08-06 | |
| 2025-12-31 | $138.00K 10-K · filed 2026-03-10 | |
| 2025-03-31 | $138.00K 10-Q · filed 2026-08-06 | |
| 2024-12-31 | $51.00K 10-K · filed 2026-03-10 | |
| 2024-09-30 | $6.00K 10-Q · filed 2025-11-12 | |
| 2024-06-30 | $22.00K 10-Q · filed 2025-11-12 | |
| 2023-12-31 | $10.00K 10-K · filed 2025-03-24 | |
| 2023-06-30 | $10.00K 10-Q · filed 2024-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |